TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2008

Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.

Lisa H Butterfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.